AU2003280315A1 - Conjugates of interleukin-10 and polymers - Google Patents

Conjugates of interleukin-10 and polymers

Info

Publication number
AU2003280315A1
AU2003280315A1 AU2003280315A AU2003280315A AU2003280315A1 AU 2003280315 A1 AU2003280315 A1 AU 2003280315A1 AU 2003280315 A AU2003280315 A AU 2003280315A AU 2003280315 A AU2003280315 A AU 2003280315A AU 2003280315 A1 AU2003280315 A1 AU 2003280315A1
Authority
AU
Australia
Prior art keywords
conjugates
interleukin
polymers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003280315A
Inventor
Kim Vilbour Andersen
Jennifer T. Jones
Claus M. Krebber
Torben Lauesgaard Nissen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maxygen Inc
Original Assignee
Maxygen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen Inc filed Critical Maxygen Inc
Publication of AU2003280315A1 publication Critical patent/AU2003280315A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003280315A 2002-11-14 2003-11-11 Conjugates of interleukin-10 and polymers Abandoned AU2003280315A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42668202P 2002-11-14 2002-11-14
US60/426,682 2002-11-14
PCT/DK2003/000774 WO2004044006A1 (en) 2002-11-14 2003-11-11 Conjugates of interleukin-10 and polymers

Publications (1)

Publication Number Publication Date
AU2003280315A1 true AU2003280315A1 (en) 2004-06-03

Family

ID=32313138

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003280315A Abandoned AU2003280315A1 (en) 2002-11-14 2003-11-11 Conjugates of interleukin-10 and polymers

Country Status (2)

Country Link
AU (1) AU2003280315A1 (en)
WO (1) WO2004044006A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2367891T3 (en) 2000-09-29 2011-11-10 Schering Corporation INTERLEUCINA-10 PEGILADA.
JP5105554B2 (en) 2006-09-28 2012-12-26 メルク・シャープ・アンド・ドーム・コーポレーション Use of pegylated IL-10 to treat cancer
EP2379115B1 (en) 2008-12-17 2017-10-25 Merck Sharp & Dohme Corp. Mono- and di-peg il-10 production; and uses
EP2457579A1 (en) * 2010-11-26 2012-05-30 Technische Universität Dresden Covalently linked interleukin -10
BR112015026122A8 (en) 2013-04-18 2020-01-21 Armo Biosciences Inc polyethylene glycol-yl-10 agent (peg-il-10), its use, pharmaceutical composition, sterile container and kit
JP2016526014A (en) * 2013-04-24 2016-09-01 アルモ・バイオサイエンシーズ・インコーポレイテッド Interleukin-10 composition and use thereof
US9823255B2 (en) 2013-06-17 2017-11-21 Armo Biosciences, Inc. Method for assessing protein identity and stability
AU2014311432A1 (en) 2013-08-30 2016-03-03 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
BR112016010166A2 (en) 2013-11-11 2017-12-05 Armo Biosciences Inc Methods for Using Interleukin-10 to Treat Diseases and Disorders
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
WO2016060996A2 (en) 2014-10-14 2016-04-21 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
CN107106655A (en) 2014-10-22 2017-08-29 阿尔莫生物科技股份有限公司 The method that disease and illness are treated using interleukin 10
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
KR20180020141A (en) 2015-05-28 2018-02-27 아르모 바이오사이언시스 인코포레이티드 PEGylated interleukin-10 for cancer treatment
WO2017035232A1 (en) 2015-08-25 2017-03-02 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CA3026393C (en) * 2016-06-22 2023-03-14 Alkermes, Inc. Compositions and methods for modulating il-10 immunostimulatory and anti-inflammatory properties
CA3117572A1 (en) * 2018-11-08 2020-05-14 Synthorx, Inc. Interleukin 10 conjugates and uses thereof
CN115175704A (en) * 2019-11-04 2022-10-11 新索思股份有限公司 Interleukin 10 conjugates and uses thereof
IL298471A (en) * 2020-05-28 2023-01-01 Univ Leland Stanford Junior Engineered interleukin-10 polypeptides and uses thereof
EP4259645A1 (en) * 2020-12-09 2023-10-18 Asher Biotherapeutics, Inc. Fusions of mutant interleukin-10 polypeptides with antigen binding molecules for modulating immune cell function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ502375A (en) * 1997-07-14 2001-11-30 Bolder Biotechnology Inc The addition of non-natural cysteine derivatives to cause the protein to act as antagonists of the GH family
AU2001231532A1 (en) * 2000-02-11 2001-08-20 Maxygen Aps Improved interleukin 10
WO2001068141A2 (en) * 2000-03-17 2001-09-20 Maxygen Aps Dispersions of polypeptide conjugates
ES2367891T3 (en) * 2000-09-29 2011-11-10 Schering Corporation INTERLEUCINA-10 PEGILADA.

Also Published As

Publication number Publication date
WO2004044006A1 (en) 2004-05-27

Similar Documents

Publication Publication Date Title
AU2003280315A1 (en) Conjugates of interleukin-10 and polymers
AU2002320058A1 (en) Magnetic-nanoparticle conjugates and methods of use
AU2003233887A1 (en) Polymers their preparation and uses
AU2003203029A1 (en) Improved health-related devices and methods
AU2003299734A1 (en) Luminescent polymers and methods of use thereof
AU2002318364A1 (en) Novel human histone deacetylases
AU2003214945A1 (en) Multi-function catheter and use thereof
AU2003293082A1 (en) Antioxidant-functionalized polymers
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2003256217A1 (en) New polymers and applications
AU2003233069A1 (en) Gel and powder making
AU2003265202A1 (en) Novel lactams and uses thereof
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2003293644A1 (en) Moldings and preparation and uses thereof
AU2003232821A1 (en) Novel phospholipases and uses thereof
AU2003296369A1 (en) Imminoamines and preparation thereof
AU2003205381A1 (en) Hpma-polyamine conjugates and uses therefore
AU2003214625A1 (en) Histone conjugates and uses thereof
AU2002354070A1 (en) Medical polymers and use thereof
AU2003281691A1 (en) Furoisoquinoline derivative and use thereof
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2002953223A0 (en) Novel therapeutic molecules and uses thereof
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase